Association of SCN2A single nucleotide polymorphisms with Parkinson’s disease: Evidence from a case-control Study.

Publication date: May 19, 2025

A growing body of strong evidence shows that voltage-gated sodium channels genes play key roles in the development of sporadic Parkinson’s disease (sPD). However, little data have been reported on the association between single nucleotide polymorphisms (SNPs) and sPD. This study aimed to investigate the association between SCN2A gene polymorphisms and sPD. 267 patients with sPD and 267 healthy controls were included in this study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression of SCN2A in the serum of patients and healthy individuals. The distribution of the G allele of rs2304016 or the A allele of rs17183814 in SCN2A was significantly higher in patients with sPD (P = 0. 001). In subtype analysis, the frequency of the rs2304016 AG heterozygote significantly differed between the early onset PD (EOPD) and late-onset PD (LOPD) groups (P 

Concepts Keywords
Allele Association
Parkinson SCN2A
Pcr Single nucleotide polymorphisms
Rs17183814 Sporadic Parkinson’s disease
Sodium Voltage-gated sodium channels

Semantics

Type Source Name
disease MESH Parkinson’s disease
disease MESH restriction fragment length polymorphism
disease MESH heterozygote

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *